查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1523252

荷尔蒙避孕药市场报告：2030 年趋势、预测与竞争分析

Hormonal Contraceptive Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

荷尔蒙避孕药的趋势和预测

到 2030 年，全球荷尔蒙避孕药市场预计将达到 198 亿美元，2024 年至 2030 年复合年增长率为 3.8%。该市场的主要驱动力是新兴经济体对荷尔蒙避孕方法的认识不断提高，以及领先公司对新型避孕设备研发的投资激增。全球荷尔蒙避孕药市场的未来看起来充满希望，荷尔蒙避孕药市场和纯黄体素市场都充满机会。

荷尔蒙避孕药细分市场

该研究包括按方法、荷尔蒙和地区对全球荷尔蒙避孕药的预测。

荷尔蒙避孕药市场洞察

Lucintel 预测，由于人们对药物的认识不断增强，药物在预测期内仍将是最大的细分市场。

在这个市场中，CHC 将继续成为更大的细分市场。

由于目标人口众多且主要企业的投资不断增加，预计亚太地区在预测期内将出现最高的成长。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球荷尔蒙避孕药市场预计将达到 198 亿美元。

Q2.市场成长预测是多少：

A2. 预计 2024 年至 2030 年全球荷尔蒙避孕药市场将以 3.8% 的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动因素是新兴经济体对荷尔蒙避孕方法的认识不断提高，以及大公司对新型避孕器具研发的投资激增。

Q4.市场的主要细分市场是：

A4. 荷尔蒙避孕药市场前景广阔，CHC 市场和纯黄体素市场都有机会。

Q5.市场的主要企业是：

A5. 主要的荷尔蒙避孕药公司如下：

  • AbbVie
  • Afaxys
  • Teva Pharmaceuticals Industries
  • Bayer
  • Organon
  • Pfizer
  • Agile Therapeutics
  • Janssen Pharmaceutical
  • Lupin Pharmaceutical
  • Pregna International

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，由于人们对药物的认识不断增强，药物在预测期内仍将是其最大的细分市场。

Q7.未来五年预计哪个地区的市场成长最大？

由于目标人口庞大且主要企业不断增加投资，A7.APAC预计将在预测期内实现最高成长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球荷尔蒙避孕药市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球荷尔蒙避孕药市场趋势（2018-2023）与预测（2024-2030）
  • 依方法分類的全球荷尔蒙避孕市场
    • 丸
    • IUD
    • 注射
    • 避孕环
    • 植入
  • 以荷尔蒙分類的全球荷尔蒙避孕药市场
    • CHC
    • 仅孕激素

第四章 2018-2030年区域市场趋势及预测分析

  • 全球荷尔蒙避孕药市场区域分布
  • 北美荷尔蒙避孕药市场
  • 欧洲荷尔蒙避孕药市场
  • 亚太地区荷尔蒙避孕药市场
  • 其他地区荷尔蒙避孕药市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球荷尔蒙避孕药市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球荷尔蒙避孕药市场的产能
    • 全球荷尔蒙避孕药市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • AbbVie
  • Afaxys
  • Teva Pharmaceuticals Industries
  • Bayer
  • Organon
  • Pfizer
  • Agile Therapeutics
  • Janssen Pharmaceutical
  • Lupin Pharmaceutical
  • Pregna International
简介目录

Hormonal Contraceptive Trends and Forecast

The future of the global hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets. The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030 with a CAGR of 3.8% from 2024 to 2030. The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Hormonal Contraceptive by Segment

The study includes a forecast for the global hormonal contraceptive by method, hormone, and region.

Hormonal Contraceptive Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Pill
  • Intrauterine Device
  • Injectable
  • Vaginal Ring
  • Implant
  • Patch

Hormonal Contraceptive Market by Hormone [Shipment Analysis by Value from 2018 to 2030]:

  • Combination Hormonal Contraceptive
  • Progestin Only

Hormonal Contraceptive Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Hormonal Contraceptive Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hormonal contraceptive companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hormonal contraceptive companies profiled in this report include-

  • AbbVie
  • Afaxys
  • Teva Pharmaceuticals Industries
  • Bayer
  • Organon
  • Pfizer
  • Agile Therapeutics
  • Janssen Pharmaceutical
  • Lupin Pharmaceutical
  • Pregna International

Hormonal Contraceptive Market Insights

Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.

Within this market, combination hormonal contraceptive will remain larger segment.

APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.

Features of the Global Hormonal Contraceptive Market

Market Size Estimates: Hormonal contraceptive market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hormonal contraceptive market size by method, hormone, and region in terms of value ($B).

Regional Analysis: Hormonal contraceptive market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different methods, hormones, and regions for the hormonal contraceptive market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hormonal contraceptive market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the hormonal contraceptive market size?

Answer: The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030.

Q2. What is the growth forecast for hormonal contraceptive market?

Answer: The global hormonal contraceptive market is expected to grow with a CAGR of 3.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the hormonal contraceptive market?

Answer: The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.

Q4. What are the major segments for hormonal contraceptive market?

Answer: The future of the hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets.

Q5. Who are the key hormonal contraceptive market companies?

Answer: Some of the key hormonal contraceptive companies are as follows:

  • AbbVie
  • Afaxys
  • Teva Pharmaceuticals Industries
  • Bayer
  • Organon
  • Pfizer
  • Agile Therapeutics
  • Janssen Pharmaceutical
  • Lupin Pharmaceutical
  • Pregna International

Q6. Which hormonal contraceptive market segment will be the largest in future?

Answer: Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.

Q7. In hormonal contraceptive market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the hormonal contraceptive market by method (pill, intrauterine device, injectable, vaginal ring, implant, and patch), hormone (combination hormonal contraceptive and progestin only), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Hormonal Contraceptive Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Hormonal Contraceptive Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Hormonal Contraceptive Market by Method
    • 3.3.1: Pill
    • 3.3.2: Intrauterine Device
    • 3.3.3: Injectable
    • 3.3.4: Vaginal Ring
    • 3.3.5: Implant
  • 3.4: Global Hormonal Contraceptive Market by Hormone
    • 3.4.1: Combination Hormonal Contraceptive
    • 3.4.2: Progestin Only

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Hormonal Contraceptive Market by Region
  • 4.2: North American Hormonal Contraceptive Market
    • 4.2.1: North American Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
    • 4.2.2: North American Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
  • 4.3: European Hormonal Contraceptive Market
    • 4.3.1: European Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
    • 4.3.2: European Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
  • 4.4: APAC Hormonal Contraceptive Market
    • 4.4.1: APAC Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
    • 4.4.2: APAC Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
  • 4.5: ROW Hormonal Contraceptive Market
    • 4.5.1: ROW Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
    • 4.5.2: ROW Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Hormonal Contraceptive Market by Method
    • 6.1.2: Growth Opportunities for the Global Hormonal Contraceptive Market by Hormone
    • 6.1.3: Growth Opportunities for the Global Hormonal Contraceptive Market by Region
  • 6.2: Emerging Trends in the Global Hormonal Contraceptive Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Hormonal Contraceptive Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hormonal Contraceptive Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AbbVie
  • 7.2: Afaxys
  • 7.3: Teva Pharmaceuticals Industries
  • 7.4: Bayer
  • 7.5: Organon
  • 7.6: Pfizer
  • 7.7: Agile Therapeutics
  • 7.8: Janssen Pharmaceutical
  • 7.9: Lupin Pharmaceutical
  • 7.10: Pregna International